McSweeney brings to TeraRecon more than 20 years of strategic healthcare experience, with a strong track record of customer-centric growth. He spent 18 years with GE Capital and GE Healthcare in multiple executive roles. Most recently, he was at Wolters Kluwer Health, where he led the company's $500 million business in the Americas.

Dan's track record of creating and expanding value through continuous solution improvement and deployment will serve the TeraRecon team well. He understands the importance of driving down barriers to adoption by making AI solutions valuable, practical, and ubiquitous.

With his strong expertise in the Healthcare, Finance, and IT sectors and his proven record of developing and executing a strategic and innovative vision, Dan will continue to lead TeraRecon into the future.

Sinan shares our drive for better patient outcomes and value through out-of-the-box solutions for streamlined efficiency and effectiveness.

Batman brings rich industry experience to TeraRecon, including Chief Engineer at Carestream/Kodak Health Group, where he defined the vision for image-centric workflow information systems. At Fujifilm Medical Systems USA, he was Executive Technical Director of Research and Development, heading the core medical IT product development and leading 200 product releases. Batman directed the Digital Innovation and Data Science Teams at Hillrom, leading the development of class-leading health risk prediction algorithms across the care continuum.

Earlier In his career, Batman has developed computer-aided diagnosis algorithms for breast cancer detection and was one of the early scientists working on quantifying gene expression using microarray imaging technologies for the US National Institutes of Health. He developed advanced autonomous medical imaging algorithms for disease and target detection as a research scientist at Johns Hopkins University. Batman modeled, simulated, and optimized quantum-well laser diodes and arrays while working as a Research Scientist at Xerox Research Labs in a NASA-sponsored project.

John has been a sales and marketing leader in the healthcare technology world for more than 25 years.  As a passionate advocate for his customers and partners, he is both a strategic visionary for disruptive innovation and an amicable driver of process efficiency and execution.   He joins TeraRecon as Chief Revenue Officer having been a part of several healthcare transformations – from PACS and EMR technology companies, to venture-backed start up solution providers to his most recent prior engagement as a founding leader of Salesforce.com’s Healthcare and Life Sciences vertical.

John is a graduate of the University of San Diego, where he currently resides with his young family.

Martin Clancy joined TeraRecon in April 2020, as Vice President of Finance & Operations .

Prior to joining TeraRecon, Martin spent 10 years at DataCore Software, an Insight Venture Partners portfolio company, as their Chief Financial Officer

Prior to joining DataCore, Martin spent 12 years at Citrix Systems in a variety of Finance and Operation positions, the last one being Senior Director, Finance and Product Operations in the Desktop Division.

Martin graduated from the University of Wales Institute of Science and Technology, Cardiff with a degree in Banking & Finance and qualified as a Chartered Accountant with KPMG in the UK.

Martin brings 30 years of Finance experience gained in a variety of industries including Distribution, Architectural Products, Healthcare and Technology.

Dr. Romesh Wadhwani is the founder and CEO of SymphonyAI Group, a fast-growing operating group of leading AI companies that deliver a new generation of advanced AI solutions to transform the enterprise. SymphonyAI Group companies focus on driving revenue growth and operational excellence for customers in their vertical sectors, including retail, CPG, life sciences, payer/provider, manufacturing and process industries, defense, financial services, and media.

Prior to founding Symphony AI Group, Dr. Wadhwani was the founder and CEO of Symphony Technology Group, a strategic private equity firm that builds great software and technology-enabled services companies. Dr. Wadhwani founded STG in 2002, growing it from startup to $ 2.5 billion in combined revenue and 15,000 employees. Dr. Wadhwani was the founder and CEO of Aspect Development Inc., a B2B software firm. Aspect Development was acquired in 2000 for $9.3 billion, the largest software acquisition at the time.

Dr. Wadhwani established the Wadhwani Foundation in 2001 to accelerate job creation and economic development in India and other emerging economies through large scale initiatives in entrepreneurship, innovation, and skilling. Today, the Wadhwani Foundation is active in India and more than 20 countries across Asia, Africa, and Latin America.


Dr. Wadhwani holds a bachelor of science degree in electrical engineering from the Indian Institute of Technology Bombay and a master’s of science and Ph.D. in electrical engineering from Carnegie Mellon University. Dr. Wadhwani received an honorary doctorate from the Indian Institute of Technology Bombay in August 2018.

McSweeney brings to TeraRecon more than 20 years of strategic healthcare experience, with a strong track record of customer-centric growth. He spent 18 years with GE Capital and GE Healthcare in multiple executive roles. Most recently, he was at Wolters Kluwer Health, where he led the company's $500 million business in the Americas.

Dan's track record of creating and expanding value through continuous solution improvement and deployment will serve the TeraRecon team well. He understands the importance of driving down barriers to adoption by making AI solutions valuable, practical, and ubiquitous.

With his strong expertise in the Healthcare, Finance, and IT sectors and his proven record of developing and executing a strategic and innovative vision, Dan will continue to lead TeraRecon into the future.

Jeff Elton, Ph.D., is CEO of ConcertAI, an AI SaaS solutions company providing research solutions and patient-centric solutions for life sciences innovators and the world’s leading providers. ConcertAI is focused on accelerating and improving the precision of retrospective and prospective clinical studies using provider EMRs, LISs, and PACSs systems as the source for all study data. It is a long-term partner partner with the American Society of Clinical Oncology and its CancerLinQ program, US FDA, NCI Health Equity initiatives, and almost 100 healthcare providers across the US.

Prior to ConcertAI, Jeff was Managing Director, Accenture Strategy/Patient Health; Global Chief Operating Officer and SVP Strategy at Novartis Institutes of BioMedical Research, Inc.; and partner at McKinsey & Company. He is also a founding board member and senior advisor to several early-stage companies. Jeff is currently a board member of the Massachusetts Biotechnology Council. He is the co-author of the widely cited book, Healthcare Disrupted (Wiley, 2016). Jeff has a Ph.D. and M.B.A. from The University of Chicago.

Pradyut Shah is a senior investment partner at SymphonyAI Group and oversees all investment and acquisition activity at the firm. He currently serves as a Director on the Boards of Symphony AzimaAI, Symphony MediaAI and Ayasdi.

Pradyut was previously a Managing Director and founding member of Insignia Capital Group, a middle-market private equity firm where he served as a Director on the Boards of portfolio companies in the consumer sector. Prior to Insignia, he was a Vice President at Behrman Capital where he was significantly involved with a number of private equity investments from 2004 to 2011, including Athena Diagnostics, Brooks Equipment Company, Peacock Engineering Company, Pelican Products and WIL Research Laboratories. Prior to Behrman, Pradyut spent 3 years at Credit Suisse First Boston’s Technology Group.

He attended the Jerome Fisher Program in Management and Technology at the University of Pennsylvania, where he graduated summa cum laude with a B.S.E. in Computer Science from the School of Engineering and Applied Science and a B.S. in Economics with a major in Finance from the Wharton School of Business.

Jeff Sorenson serves on the board of directors of TeraRecon, an enterprise AI company for medical imaging for which he also served as president and CEO. He is a member of the board of advisors for SymphonyAI, an operating company focused on enterprise AI across multiple industries. Prior to TeraRecon, he held leadership positions at Hyland Software, GE, Imatron, and Philips. He earned a Bachelor of Science in Electrical Engineering from the University of Wisconsin and an M.B.A. from Cardinal Stritch University in Minnesota.

Jeff holds a Bachelor of Science in Electrical Engineering from the University of Wisconsin and an M.B.A. from Cardinal Stritch University in Minnesota.